Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG42988

CCDC186 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The CCDC186 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout population designed for functional studies of the coiled?coil domain?containing protein CCDC186. CCDC186 is predicted to serve as a molecular scaffold mediating interactions with actin filaments, microtubules, and motor proteins, thereby influencing cytoskeletal organization and vesicular transport. Derived from the HEK293T human embryonic kidney cell line, this model provides a tractable system to investigate CCDC186??s role in intracellular trafficking and organelle positioning. Key applications include protein expression validation by western blotting, interaction partner discovery via co?immunoprecipitation and mass spectrometry, and transcriptional analysis using RT?qPCR.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    CCDC186

    Gene Identifier

    NCBI Gene ID 55088

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC186 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the human CCDC186 gene. This product comprises a heterogeneous mix of HEK293T cells carrying diverse editing events at the CCDC186 locus, enabling gene-level loss-of-function studies without the need for clonal selection. The polyclonal format reduces clonal bias and preserves natural biological variation, providing a robust and versatile tool for functional genomics research. Cells can be used directly in endpoint assays to interrogate CCDC186??s cellular roles.

The parental HEK293T cell line is a widely used human embryonic kidney epithelial model, engineered to constitutively express the SV40 large T antigen. This modification supports episomal replication of plasmids containing the SV40 origin, leading to high transient protein expression and efficient production of viral vectors. HEK293T cells are valued for their rapid proliferation, ease of transfection, and compatibility with biochemical and imaging techniques. Their well-characterized molecular landscape ensures a consistent background for studying gene function, protein interactions, and signaling pathways.

CCDC186 contains coiled?coil domains and is predicted to function as a molecular scaffold in cytoskeletal and membrane trafficking networks. It likely facilitates interactions with actin filaments, microtubules, and motor proteins, thereby contributing to the spatial regulation of organelle positioning and intracellular transport. While upstream activators and downstream effectors remain uncharacterized, CCDC186 is hypothesized to operate at the interface of cytoskeletal dynamics and vesicle trafficking. Disruption of CCDC186 is expected to destabilize these scaffolding complexes, offering a valuable model for dissecting its mechanistic roles in intracellular organization.

In the HEK293T context, CCDC186 knockout provides a relevant system to study the protein??s impact on epithelial cell architecture. Loss of CCDC186 may result in altered organelle distribution or vesicular trafficking, phenotypes that can be directly monitored by live?cell imaging and immunofluorescence microscopy. The cell line??s susceptibility to transient transfection and stable expression allows for rescue experiments and pathway modulation studies. As a polyclonal population, this model avoids clonal artifacts and reflects the heterogeneity of gene?edited cell responses, facilitating robust phenotypic analysis.

This polyclonal knockout product is suited for a comprehensive set of research applications, including validation of protein depletion by western blotting and quantitative immunofluorescence, identification of interacting proteins via co?immunoprecipitation coupled with mass spectrometry, and assessment of downstream transcriptional changes through RT?qPCR. The polyclonal nature of the pool ensures that observed phenotypes are not skewed by single?cell adaptation, making it an ideal choice for unbiased functional studies. For further technical details or custom gene?editing inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)